01.30.26 -- Reclaiming Control From Your Raw Materials

If you want to increase speed and reduce costs while still procuring high-quality data for your clinical trial, consider the impact of launching an early-phase clinical trial in Australia.

How did Quest help a leading pharmaceutical company overcome the data latency challenges associated with traditional EHR when recruiting eligible patients for a rare blood disorder drug?

Gain valuable insights into the role of sponsor-side Clinical Operations leadership, the risks of over-relying on CROs, and key strategies for fostering collaboration between sponsors and partners.

Learn how model-informed development that integrates preclinical and literature-based data is enabling smarter predictions of exposure and safety, transforming psychedelic research and advancing clinical innovation.

Watch and see how in vivo CAR-T technology is opening new therapeutic frontiers for autoimmune disorders — and what the field must accomplish to convert early scientific promise into meaningful patient outcomes.

Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences, explores the methodology behind the operating company’s role in the clinical trial industry.